BEVACIZUMAB IN RECURRENT MALIGNANT GLIOMA, A SINGLE INSTITUTION EXPERIENCE

被引：0
|
作者：
Cunha, J. [1 ]
Almeida, M. [1 ]
Couto, E. [1 ]
Amorim, J. [1 ]
Nabico, R. [1 ]
机构：
[1] Hosp Braga, Braga, Portugal
来源：
NEURO-ONCOLOGY | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P09.06
引用
收藏
页码：71 / 71
页数：1
相关论文
共 50 条
  • [1] Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience
    Mesti, Tanja
    Moltara, Maja Ebert
    Boc, Marko
    Rebersek, Martina
    Ocvirk, Janja
    RADIOLOGY AND ONCOLOGY, 2015, 49 (01) : 80 - 85
  • [2] Bevacizumab for recurrent malignant glioma - a single institution experience with 120 patients
    Platten, M.
    Wick, A.
    Lemke, D.
    Loew, S.
    Schemmer, D.
    Wick, W.
    ONKOLOGIE, 2010, 33 : 57 - 57
  • [3] A single institution's experience with bevacizumab and cytoxic chemotherapy in progressive malignant glioma
    Mayer, T. M.
    Lacy, J.
    Baehring, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Single Agent Bevacizumab for Recurrent Malignant Glioma
    Cadoo, K.
    O'Brien, M.
    Grogan, L.
    Breathnach, O.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S588 - S588
  • [5] A Single Institution's Experience with Bevacizumab in Combination with Cytotoxic Chemotherapy in Progressive Malignant Glioma
    Mayer, Tina
    Lacy, Jill
    Baehring, Joachim
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2008, 2 : 455 - 459
  • [6] Bevacizumab in recurrent malignant glioma
    Lauren E. Abrey
    Current Neurology and Neuroscience Reports, 2008, 8 (3) : 233 - 234
  • [7] BEVACIZUMAB IN PATIENTS WITH RECURRENT HIGH-GRADE MALIGNANT GLIOMA: SINGLE-CENTER EXPERIENCE
    Smolin, Alexey V.
    Konev, Andrey
    Nikolaeva, Sverlana
    Shamanskaya, Yulia
    Malysheva, Alexandra
    Strelnikov, Vladimir
    NEURO-ONCOLOGY, 2010, 12 : 43 - 43
  • [8] Carboplatin and bevacizumab for recurrent malignant glioma
    Mrugala, Maciej M.
    Crew, Laurie K.
    Fink, James R.
    Spence, Alexander M.
    ONCOLOGY LETTERS, 2012, 4 (05) : 1082 - 1086
  • [9] Valganciclovir and bevacizumab for recurrent glioblastoma: A single-institution experience
    Peng, Chengwei
    Wang, Jialing
    Tanksley, Jarred P.
    Mobley, Bret C.
    Ayers, Gregory D.
    Moots, Paul L.
    Clark, Stephen W.
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (02) : 154 - 158
  • [10] Bevacizumab and chemotherapy for recurrent glioblastoma A single-institution experience
    Nghiemphu, P. L.
    Liu, W.
    Lee, Y.
    Than, T.
    Graham, C.
    Lai, A.
    Green, R. M.
    Pope, W. B.
    Liau, L. M.
    Mischel, P. S.
    Nelson, S. F.
    Elashoff, R.
    Cloughesy, T. F.
    NEUROLOGY, 2009, 72 (14) : 1217 - 1222
12345